FB-401(Freya Biosciences)

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameFB-401(Freya Biosciences)
Drug Alias NameFB-401FB401
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsPremature Birth
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFreya Biosciences APS
China Registration ClassN/A

Develop Information

Active CompaniesFreya Biosciences APS
Inactive CompaniesN/A
Active IndicationsPremature Birth
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A